Cargando…

The Rate of Conversion from Immune-tolerant Phase to Early Immune-clearance Phase in Children with Chronic Hepatitis B Virus Infection

PURPOSE: The spontaneous seroconversion rate of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) virus infection in children is lower than that in adults. However, few studies have investigated the rate of transition from the immune-tolerant to the early immune-clearance phase in chi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Suk Jin, Park, Hyo Jung, Chu, Mi Ae, Choi, Bong Seok, Choe, Byung-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990782/ https://www.ncbi.nlm.nih.gov/pubmed/24749087 http://dx.doi.org/10.5223/pghn.2014.17.1.41

Ejemplares similares

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
por: Lee, Han Ah, et al.
Publicado: (2023)

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
por: Chu, Chia-Ming, et al.
Publicado: (2023)

Gastrointestinal Tract Involvement of Gorham's Disease with Expression of D2-40 in Duodenum
por: Choi, Bong Seok, et al.
Publicado: (2014)

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes
por: Li, Ya-Nan, et al.
Publicado: (2022)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2021)

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Differences in Features and Course of Mucosal Type Eosinophilic Gastroenteritis between Korean Infants and Children
por: Choi, Bong Seok, et al.
Publicado: (2015)

Pentose Phosphate Pathway Regulates Tolerogenic Apoptotic Cell Clearance and Immune Tolerance
por: He, Dan, et al.
Publicado: (2022)

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity
por: Chang, Ming-Ling, et al.
Publicado: (2016)

Changing Prevalence of Helicobacter pylori Infections in Korean Children with Recurrent Abdominal Pain
por: Jang, Kyung Mi, et al.
Publicado: (2015)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Notch regulates Histoplasma capsulatum clearance in mouse lungs during innate and adaptive immune response phases in primary infection
por: Huang, Shuo, et al.
Publicado: (2022)

Author Correction: Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Soluble immune markers in the different phases of chronic hepatitis B virus infection
por: Wiegand, Steffen B., et al.
Publicado: (2019)

Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma
por: Kim, Hong Kwan, et al.
Publicado: (2020)

Phase separation in immune regulation and immune-related diseases
por: Huang, Ning, et al.
Publicado: (2022)

Prediction Algorithm of Parameters of Toe Clearance in the Swing Phase
por: Miyake, Tamon, et al.
Publicado: (2019)

The Immune Response in Measles: Virus Control, Clearance and Protective Immunity
por: Griffin, Diane E.
Publicado: (2016)

The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase
por: Ko, Wang-Sheng, et al.
Publicado: (2020)

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Immune complex-induced apoptosis and concurrent immune complex clearance are anti-inflammatory neutrophil functions
por: Karmakar, Utsa, et al.
Publicado: (2021)

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
por: Kennedy, Patrick T. F., et al.
Publicado: (2017)

Unresolved issues of immune tolerance in chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2020)

Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD
por: Diniz, Ariane Barros, et al.
Publicado: (2020)

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection
por: Li, Na, et al.
Publicado: (2017)

Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP
por: Mohamadkhani, Ashraf, et al.
Publicado: (2015)

Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues
por: Noguchi, Youichiro, et al.
Publicado: (1998)

Immune clearance of highly pathogenic SIV infection
por: Hansen, Scott G., et al.
Publicado: (2013)

ARF: Connecting senescence and innate immunity for clearance
por: Kearney, Alper Y., et al.
Publicado: (2015)

Lymphatic Clearance of Immune Cells in Cardiovascular Disease
por: Ravaud, Christophe, et al.
Publicado: (2021)

Plasmodium falciparum Clearance Rates in Response to Artesunate in Malian Children With Malaria: Effect of Acquired Immunity
por: Lopera-Mesa, Tatiana M., et al.
Publicado: (2013)

Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
por: Choi, Sujin, et al.
Publicado: (2021)

Macrophage Dicer promotes tolerogenic apoptotic cell clearance and immune tolerance by inhibiting pentose phosphate pathway activity
por: Mao, Qiangdongzi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67q9ubiegnp63pdosrvhc0j622